99 related articles for article (PubMed ID: 3746668)
1. Effects of ketoconazole on cholesterol synthesis.
Kraemer FB; Spilman SD
J Pharmacol Exp Ther; 1986 Sep; 238(3):905-11. PubMed ID: 3746668
[TBL] [Abstract][Full Text] [Related]
2. Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity by ketoconazole. A role for cytochrome P-450 in the regulation of HMG-CoA reductase in rat intestinal epithelial cells.
Gupta A; Sexton RC; Rudney H
J Biol Chem; 1986 Jun; 261(18):8348-56. PubMed ID: 3722155
[TBL] [Abstract][Full Text] [Related]
3. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
Iglesias J; Gibbons GF
Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
[TBL] [Abstract][Full Text] [Related]
4. Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in Hep G2 cells.
Kempen HJ; van Son K; Cohen LH; Griffioen M; Verboom H; Havekes L
Biochem Pharmacol; 1987 Apr; 36(8):1245-9. PubMed ID: 3036162
[TBL] [Abstract][Full Text] [Related]
5. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations.
Nguyen LB; Salen G; Shefer S; Tint GS; Ruiz F
Metabolism; 2001 Oct; 50(10):1224-9. PubMed ID: 11586498
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of low density lipoprotein suppression of HMG-CoA reductase activity in cultured cells by inhibitors of cholesterol biosynthesis.
Gupta AK; Sexton RC; Rudney H
J Lipid Res; 1990 Feb; 31(2):203-15. PubMed ID: 2324644
[TBL] [Abstract][Full Text] [Related]
7. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol.
Song BL; Javitt NB; DeBose-Boyd RA
Cell Metab; 2005 Mar; 1(3):179-89. PubMed ID: 16054061
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells.
Yanagita T; Yamamoto K; Ishida S; Sonda K; Morito F; Saku K; Sakai T
Clin Ther; 1994; 16(2):200-8. PubMed ID: 8062316
[TBL] [Abstract][Full Text] [Related]
10. Modulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by azole antimycotics requires lanosterol demethylation, but not 24,25-epoxylanosterol formation.
Favata MF; Trzaskos JM; Chen HW; Fischer RT; Greenberg RS
J Biol Chem; 1987 Sep; 262(25):12254-60. PubMed ID: 3624255
[TBL] [Abstract][Full Text] [Related]
11. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the kinetics of 3-hydroxy-3-methylglutaryl coenzyme A reductase and [14C]-acetate incorporation into cholesterol in human lymphocytes stimulated by phytohemagglutinin or sterol efflux.
Tabacik C; Astruc M; Laporte M; Descomps B; Crastes de Paulet A; Serrou B
Biomedicine; 1981 Dec; 34(3):128-32. PubMed ID: 7337799
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
Cenedella RJ
Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells.
Fernández C; Suárez Y; Ferruelo AJ; Gómez-Coronado D; Lasunción MA
Biochem J; 2002 Aug; 366(Pt 1):109-19. PubMed ID: 12162789
[TBL] [Abstract][Full Text] [Related]
16. A relationship between the activities of hepatic lanosterol 14 alpha-demethylase and 3-hydroxy-3-methylglutaryl-CoA reductase.
Marco de la Calle C; Hwang W; Pullinger CR; Gibbons GF
Biochem J; 1988 Feb; 250(1):33-9. PubMed ID: 3355520
[TBL] [Abstract][Full Text] [Related]
17. Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes.
Goad LJ; Holz GG; Beach DH
Mol Biochem Parasitol; 1985 Jun; 15(3):257-79. PubMed ID: 4033689
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
[TBL] [Abstract][Full Text] [Related]
19. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Anderson JA; Leonard DA; Cusack KP; Frye LL
Arch Biochem Biophys; 1995 Jan; 316(1):190-6. PubMed ID: 7840615
[TBL] [Abstract][Full Text] [Related]
20. Oxidative metabolism of cholesterol precursors: sensitivity to ketoconazole, an inhibitor of cytochrome P-450.
Iglesias J; Gibbons GF
Steroids; 1989; 53(3-5):311-28. PubMed ID: 2799848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
